ArticleThe oncologist2016

Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer.

Neeraj Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.